|
ChiCTR注册号: Reg No. in ChiCTR: |
ChiCTR2500106805 | ||||||||||||||||||||||
|
研究题目: |
A prospective multi-center randomized controlled clinical trial for the efficacy and safety of balloon uterine stent for prevention of Asherman Syndrome among patients with missed abortion after uterine curettage |
||||||||||||||||||||||
|
Study title: |
A prospective multi-center randomized controlled clinical trial for the efficacy and safety of balloon uterine stent for prevention of Asherman Syndrome among patients with missed abortion after uterine curettage |
||||||||||||||||||||||
|
注册状况: Registration: |
True |
||||||||||||||||||||||
|
注册机构: |
上海市生物医药技术研究院 |
||||||||||||||||||||||
|
Name of the Registry: |
Shanghai Institute for Biomedical and Pharmaceutical Technologies |
||||||||||||||||||||||
|
项目负责人: |
上海市生物医药技术研究院 |
||||||||||||||||||||||
|
Corresponding person: |
Shanghai Institute for Biomedical and Pharmaceutical Technologies |
||||||||||||||||||||||
|
电话: Telephone: |
+86 21 6402 3705 | ||||||||||||||||||||||
|
电子邮件 |
2045338537@qq.com |
||||||||||||||||||||||
|
通讯地址: |
上海市徐汇区老沪闵路779号 |
||||||||||||||||||||||
|
Address: |
No.779, Laohumin Road, Xuhui District, Shanghai City, China |
||||||||||||||||||||||
|
邮政编码 Postcode |
200237 |
||||||||||||||||||||||
|
项目负责人所有单位: |
上海市生物医药技术研究院 |
||||||||||||||||||||||
|
Institution: |
Shanghai Institute for Biomedical and Pharmaceutic |
||||||||||||||||||||||
|
批准本研究的伦理委员会名称: |
上海市生物医药技术研究院医学伦理委员会 |
||||||||||||||||||||||
|
Name of the ethic committee: |
The Medical Ethical Committee, Shanghai Institute |
||||||||||||||||||||||
|
研究疾病: |
|||||||||||||||||||||||
|
Study Ailment: |
|||||||||||||||||||||||
|
研究所处阶段: Study phase: |
Post-market | ||||||||||||||||||||||
|
研究类型: Type of Study: |
Therapy Study | ||||||||||||||||||||||
|
研究团队: |
车焱 李玉艳 张妍 蒋伊石 武冰雪 |
||||||||||||||||||||||
|
Research team: |
Yan Che Yuyan Li Yan Zhang Yishi Jiang Bingxue Wu |
||||||||||||||||||||||
|
研究实施地点: Site of Study: |
|
||||||||||||||||||||||
|
预计起止时间: Planned Duration: |
2025/7/1 0:00:00-2027/12/31 0:00:00 | ||||||||||||||||||||||




